Company overview
Celonic Group is a Switzerland-based biologics CDMO offering end-to-end drug substance development and manufacturing for monoclonal antibodies, bispecifics, and complex molecules. Services span cell line development, process optimization, clinical and commercial manufacturing up to 2,000L scale, with Swissmedic GMP certification. They leverage advanced technologies like perfusion bioprocessing and partner for fill-and-finish via strategic alliances.
Celonic is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include celonic group, biologics cdmo, monoclonal antibodies, cell line development, perfusion bioprocessing.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Celonic include Cdmo — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.celonic.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- celonic group, biologics cdmo, monoclonal antibodies, cell line development, perfusion bioprocessing
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biologics does Celonic Group specialize in developing and manufacturing?
- Celonic specializes in monoclonal antibodies (mAbs), bispecifics, fusion proteins, growth hormones, blood factors, and other complex molecules using CHO-based systems like CHOvolution and GS-CHOvolution.
- What are Celonic Group's manufacturing capabilities and regulatory status?
- They offer up to 2,000L GMP and R&D scale batches in fed-batch, N-1, and full-perfusion processes at sites in Heidelberg and Basel, with Swissmedic GMP certification and support for IND/BLA/MAA filings.
- Where are Celonic Group's facilities located and what geographies do they serve?
- Facilities are in Heidelberg, Germany, and Basel, Switzerland; they partner with global biotech and biosimilar companies worldwide, including strategic alliances for fill-and-finish and ADCs.
Related editorial coverage
- The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
